Hiroshi Murodumi
Overview
Explore the profile of Hiroshi Murodumi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shigeishi H, Yokoyama S, Murodumi H, Sakuma M, Fukada S, Okuda S, et al.
J Oral Pathol Med
. 2021 Sep;
51(3):281-289.
PMID: 34551150
Background: Melatonin is a hormone that is primarily produced in the pineal gland and is involved in wide range of biological functions. However, the impact of melatonin on chemotherapy-induced cell...
2.
Yokoyama S, Shigeishi H, Murodumi H, Sakuma M, Ono S, Tobiume K, et al.
Eur J Oral Sci
. 2021 Jul;
129(5):e12812.
PMID: 34236115
We previously found that microRNAs play major roles in the maintenance of amoeboid-like oral squamous cell carcinoma (OSCC) cells with high expression of CD44 (CD44 ). However, the roles of...
3.
Su C, Shigeishi H, Murodumi H, Sugiyama M, Ohta K, Takemoto T
Exp Ther Med
. 2021 May;
22(1):767.
PMID: 34055066
Previous studies have demonstrated that oral Epstein-Barr virus (EBV) is associated with periodontitis. However, the relationship between periodontitis and oral EBV has not been fully elucidated by reducing the effects...
4.
Yokoyama S, Shigeishi H, Murodumi H, Sakuma M, Kato H, Higashikawa K, et al.
J Oral Pathol Med
. 2020 Oct;
50(2):155-164.
PMID: 33107637
Background: The objective of this study was to clarify the molecular mechanism of amoeboid-to-mesenchymal transition (AMT) of CD44 oral squamous cell carcinoma (OSCC) cells. Methods: Morphology and expression of mesenchymal...
5.
Murodumi H, Shigeishi H, Kato H, Yokoyama S, Sakuma M, Tada M, et al.
Mol Med Rep
. 2020 Sep;
22(4):3549-3558.
PMID: 32945514
Our previous study revealed that treatment with a combination of fibroblast growth factor‑2 and melatonin (MEL) synergistically augmented osteogenic activity and mineralization of MC3T3‑E1 mouse preosteoblast cells. Thus, the objective...
6.
Takechi M, Ishioka Y, Ninomiya Y, Ono S, Tada M, Nakagawa T, et al.
Materials (Basel)
. 2020 Jun;
13(11).
PMID: 32521622
Background: Primary stability is an important prognostic factor for dental implant therapy. In the present study, we evaluate the relationship between implant stability evaluation findings by the use of an...
7.
Nakagawa T, Ohta K, Uetsuki R, Kato H, Naruse T, Murodumi H, et al.
Biochem Genet
. 2020 Apr;
58(3):473-489.
PMID: 32274606
Bisphosphonate-related osteonecrosis of the jaw (ONJ) is a major oral complication; however, its pathogenesis remains unclear. Impairment of osteoclast differentiation by bisphosphonates may be associated with the pathogenesis of ONJ....
8.
Shigeishi H, Yokoyama S, Murodumi H, Sakuma M, Kato H, Higashikawa K, et al.
Int J Clin Exp Pathol
. 2020 Jan;
12(8):2826-2836.
PMID: 31934119
The stiffness of extracellular matrix (ECM) has been associated with tumor growth, phenotypic plasticity, and invasion through modulation of the intracellular signaling pathway. However, the effect of ECM stiffness on...